Platelet-Rich Fibrin for treating temporomandibular disorders in adults: a Scoping Review protocol




Platelet-rich fibrin, Research gaps, Scoping review, Temporomandibular joint disorders


INTRODUCTION: Different biologically active products have been applied for management of pain and mandibular functional disability in intra-articular TMD but without the ability to effectively control degenerative joint disease. Platelet concentrates aim to enhance tissue healing and facilitate its regeneration. Intra-articular injections of liquid Platelet-Rich Fibrin (PRF) in patients with TMD have demonstrated effectiveness in the management of pain and dysfunction, also having a stimulatory effect on cartilage and bone tissues. OBJECTIVE:  The objective of this review is to examine how research has been conducted regarding use of PRF as a treatment tool for temporomandibular joint disorders (TMD). INCLUSION CRITERIA: This review will focus on studies that address adults with TMD without restrictions on gender or ethnicity. TMD will be classified according to the Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) physical axis (Axis I). Also, we will include publications in any language or date of publication.  METHODS: This protocol will follow the JBI guidance for Scoping Reviews. We shall conduct a literature search to identify published research, with no limits on year of publication/conception, format, or language. Two independent reviews will screen and select publications, based on inclusion criteria. Review decision process will be provided in a flowchart based on Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) recommendations for Scoping Reviews. Finally, we shall present extracted data from each study in piloted forms in conceptual categories such as intervention type, population and sample size, duration of intervention, aims, methodology adopted, key findings and gaps in the research.


Download data is not yet available.

Author Biography

Thayanne Calcia, Faculdade de Medicina de Petrópolis (Petrópolis). Rio de Janeiro, Brazil.




Goldstein BH. Temporomandibular disorders: A review of current understanding. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999;88(4):379–85.

Solberg WK, Woo MW, Houston JB. Prevalence of mandibular dysfunction in young adults. J Am Dent Assoc. 1979;98(1):25–34.

Schiffman E, Ohrbach R, Truelove E, Look J, Anderson G, Goulet J-P, et al. Diagnostic criteria for Temporomandibular Disorders (DC/TMD) for clinical and research applications: recommendations of the International RDC/TMD Consortium Network* and Orofacial Pain Special Interest Group. J Oral Facial Pain Headache. 2014;28(1):6–27.

Escoda-Francolí J, Vázquez-Delgado E, Gay-Escoda C. Scientific evidence on the usefulness of intraarticular hyaluronic acid injection in the management of temporomandibular dysfunction. Med Oral Patol Oral Cir Bucal. 2010;15(4):e644-8.

Manfredini D, Piccotti F, Guarda-Nardini L. Hyaluronic acid in the treatment of TMJ disorders: A systematic review of the literature. Cranio. 2010;28(3):166–76.

Marx RE, Carlson ER, Eichstaedt RM, Schimmele SR, Strauss JE, Georgeff KR. Platelet-rich plasma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998;85(6):638–46.

Dohan DM, Choukroun J, Diss A, Dohan SL, Dohan AJJ, Mouhyi J, et al. Platelet-rich fibrin (PRF): A second-generation platelet concentrate. Part II: Platelet-related biologic features. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;101(3):e45-50.

Choukroun J, Diss A, Simonpieri A, Girard MO, Schoeffler C, Dohan SL, et al. Platelet-rich fibrin (PRF): A second-generation platelet concentrate. Part IV: Clinical effects on tissue healing. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;101(3):e56–60.

Dohan Ehrenfest DM, Rasmusson L, Albrektsson T. Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF). Trends Biotechnol. 2009;27(3):158–67.

Dohan Ehrenfest DM, de Peppo GM, Doglioli P, Sammartino G. Slow release of growth factors and thrombospondin-1 in Choukroun’s platelet-rich fibrin (PRF): A gold standard to achieve for all surgical platelet concentrates technologies. Growth Factors. 2009;27(1):63–9.

Albilia JB, Vizcaíno-Herrera C, Weisleder H, Choukroun J, Ghanaati S. Liquid platelet-rich fibrin injections as a treatment adjunct for painful temporomandibular joints: preliminary results. Cranio. 2020:38(5):292-304.

Yuce E, Komerik N. Comparison of the efficiacy of intra-articular injection of liquid platelet-rich fibrin and hyaluronic acid after in conjunction with arthrocentesis for the treatment of Internal Temporomandibular Joint Derangements. J Craniofac Surg. 2020;31(7):1870–4.

Torul D, Cezairli B, Kahveci K. The efficacy of intra-articular injectable Platelet-Rich Fibrin application in the management of Wilkes stage III temporomandibular joint internal derangement. Int J Oral Maxillofac Surg. 2021;50(11):1485-90.

Karadayi U, Gursoytrak B. Randomised controlled trial of arthrocentesis with or without PRF for internal derangement of the TMJ. J Craniomaxillofac Surg. 2021;49(5):362–7.

González LV, López JP, Díaz-Báez D, Orjuela MP, Chavez M. Clinical outcomes of operative arthroscopy and temporomandibular medical infiltration with platelet-rich fibrin in upper and lower articular space. J Craniomaxillofac Surg. 2021;49(12):1162-8.

Peters MDJ, Godfrey C, McInerney P, Munn Z, Tricco AC, Khalil H. Scoping reviews [Internet]. In: Aromataris E, Munn Z, editors. Joanna Briggs Institute Reviewer's Manual. Australia: Joanna Briggs Institute; 2020. Available from:

Tricco AC, Lillie E, Zarin W, O’Brien KK, Colquhoun H, Levac D, et al. PRISMA Extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169(7):467-73.

Miron RJ, Fujioka-Kobayashi M, Hernandez M, Kandalam U, Zhang Y, Ghanaati S, et al. Injectable platelet rich fibrin (i-PRF): opportunities in regenerative dentistry? Clin Oral Investig. 2017;21(8):2619–27.

Miron RJ, Zhang Y. Autologous liquid platelet rich fibrin: A novel drug delivery system. Acta Biomater. 2018;15(75):35-51.




How to Cite

Tesch, R. ., Takamori, E. ., Calcia, T., Lobo, F., Leitão, E., & Fontes , L. E. . (2022). Platelet-Rich Fibrin for treating temporomandibular disorders in adults: a Scoping Review protocol . Journal of Evidence-Based Healthcare, 4, e4165.



Registered Reports